Feng Jin
Impact in
- Otorhinolaryngology top 0.2%
- Head and Neck Cancer Studies
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- Viral-associated cancers and disorders
- Inflammatory Biomarkers in Disease Prognosis
Papers in
-
- Head and Neck Cancer Studies 31
-
- Circadian rhythm and melatonin 3
- Co-authors
- Wei-Li Wu (10 shared papers)Jinhua Long (13 shared papers)Xiaoxia Gou (3 shared papers)Yuanyuan Li (6 shared papers)Li Ma (1 shared paper)Hạixia Chen (2 shared papers)Yecai Huang (1 shared paper)Qinghua Jiang (1 shared paper)
In The Last Decade
Feng Jin
36 papers receiving 2k citations
Feng Jin's Hit Papers
Peers
Comparison fields: 5 of 74
- Otorhinolaryngology 1.3k
- Oncology 380
- Endocrine and Autonomic Systems 44
- Cancer Research 92
- Pulmonary and Respiratory Medicine 104
Countries citing papers authored by Feng Jin
This map shows the geographic impact of Feng Jin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feng Jin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feng Jin more than expected).
Fields of papers citing papers by Feng Jin
This network shows the impact of papers produced by Feng Jin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feng Jin. The network helps show where Feng Jin may publish in the future.
Co-authors
The 25 scholars most cited alongside Feng Jin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 39 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma Hit paper breakdown → | 2019 | 694 |
| 2 | Toripalimab or placebo plus chemotherapy as first-line treatment in advanced nasopharyngeal carcinoma: a multicenter randomized phase 3 trial Hit paper breakdown → | 2021 | 306 |
| 3 | The Chinese Society of Clinical Oncology (CSCO) clinical guidelines for the diagnosis and treatment of nasopharyngeal carcinoma Hit paper breakdown → | 2021 | 276 |
| 4 | Metronomic capecitabine as adjuvant therapy in locoregionally advanced nasopharyngeal carcinoma: a multicentre, open-label, parallel-group, randomised, controlled, phase 3 trial Hit paper breakdown → | 2021 | 159 |
| 5 | Toripalimab Plus Chemotherapy for Recurrent or Metastatic Nasopharyngeal Carcinoma Hit paper breakdown → | 2023 | 156 |
| 6 | Final Overall Survival Analysis of Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma: A Multicenter, Randomized Phase III Trial Hit paper breakdown → | 2022 | 109 |
| 7 | 2016 | 41 | |
| 8 | 2013 | 30 | |
| 9 | 2023 | 27 | |
| 10 | 2020 | 24 | |
| 11 | 2018 | 22 | |
| 12 | 2024 | 19 | |
| 13 | 2025 | 18 | |
| 14 | 2019 | 17 | |
| 15 | 2023 | 17 | |
| 16 | 2018 | 15 | |
| 17 | 2022 | 13 | |
| 18 | 2018 | 11 | |
| 19 | [Phase II clinical trial of two different modes of administration of the induction chemotherapy for locally advanced nasopharyngeal carcinoma]. | 2015 | 10 |
| 20 | 2019 | 10 |
About Feng Jin
Feng Jin is a scholar working on Otorhinolaryngology, Endocrine and Autonomic Systems, Cancer Research, Oncology and Immunology, having authored 39 papers that have together received 2k indexed citations. Recurring topics across this work include Head and Neck Cancer Studies (31 papers), Circadian rhythm and melatonin (3 papers), Cancer Immunotherapy and Biomarkers (3 papers), Protease and Inhibitor Mechanisms (2 papers), Cancer, Hypoxia, and Metabolism (1 paper), Oral health in cancer treatment (1 paper), Phagocytosis and Immune Regulation (1 paper) and Lymphoma Diagnosis and Treatment (1 paper). The work is most often cited by research in Otorhinolaryngology (1.3k citations), Oncology (380 citations), Endocrine and Autonomic Systems (44 citations), Cancer Research (92 citations) and Pulmonary and Respiratory Medicine (104 citations). Feng Jin has collaborated with scholars based in China, Singapore and Belgium. Frequent co-authors include Wei-Li Wu, Jinhua Long, Xiaoxia Gou, Yuanyuan Li, Li Ma, Hạixia Chen, Yecai Huang, Qinghua Jiang, Yuanyuan Li and Zhuolin Li. Their work appears in journals such as JAMA, Chronobiology International, Journal of Clinical Oncology, Oral Oncology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.